Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

Cantor Fitzgerald reaffirmed its Overweight rating on ALX Oncology (NASDAQ:ALXO), following the presentation of positive Phase 2 ASPEN-6 study results. According to InvestingPro data, the company's ...

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast ...

AbbVie and Neomorph are set to enter a partnership and option-to-license agreement to develop molecular glue degraders.

ALX Oncology is forging ahead with a treatment approach that has long been abandoned by other drugmakers, eyeing a potential ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

The Federal Government of Nigeria has launched a leadership programme for women in oncology, aimed at promoting inclusiveness ...

Kauvery Cancer Institute offers advanced cancer care with robotic surgery, early detection campaigns, and holistic support, ...

Lucknow: KGMU has launched a dedicated gynae oncology department that will provide specialised care under one roof, as gynaecological related cancers .

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...